Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making

被引:3
作者
Ramasco, Fernando [1 ]
Mendez, Rosa [1 ]
de la Rica, Alejandro Suarez [1 ]
de Castro, Rafael Gonzalez [2 ]
Maseda, Emilio [3 ]
机构
[1] Hosp Univ La Princesa, Dept Anaesthesiol & Surg Intens Care, Diego Leon 62, Madrid 28006, Spain
[2] Univ Hosp Leon, Dept Rheumatol, Leon 24071, Spain
[3] Hosp Univ Fdn Alcorcon, Dept Traumatol & Orthopaed Surg, Madrid, Spain
来源
JOURNAL OF PERSONALIZED MEDICINE | 2024年 / 14卷 / 01期
关键词
Antimicrobial Stewardship; sparing carbapenems; new antibiotics; antimicrobial resistance; individualization; antibiotic treatment; sepsis; septic shock; Gram negatives; VENTILATOR-ASSOCIATED PNEUMONIA; INFECTIOUS-DISEASES SOCIETY; INTENSIVE-CARE-UNIT; BETA-LACTAM ANTIBIOTICS; CRITICALLY-ILL PATIENTS; ANTIMICROBIAL THERAPY; SEPTIC SHOCK; CLINICAL MICROBIOLOGY; AMERICAN-COLLEGE; EUROPEAN-SOCIETY;
D O I
10.3390/jpm14010106
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The main recent change observed in the field of critical patient infection has been universal awareness of the need to make better use of antimicrobials, especially for the most serious cases, beyond the application of simple and effective formulas or rigid protocols. The increase in resistant microorganisms, the quantitative increase in major surgeries and interventional procedures in the highest risk patients, and the appearance of a significant number of new antibiotics in recent years (some very specifically directed against certain mechanisms of resistance and others with a broader spectrum of applications) have led us to shift our questions from "what to deal with" to "how to treat". There has been controversy about how best to approach antibiotic treatment of complex cases of sepsis. The individualized and adjusted dosage, the moment of its administration, the objective, and the selection of the regimen are pointed out as factors of special relevance in a critically ill patient where the frequency of resistant microorganisms, especially among the Enterobacterales group, and the emergence of multiple and diverse antibiotic treatment alternatives have made the appropriate choice of antibiotic treatment more complex, requiring a constant updating of knowledge and the creation of multidisciplinary teams to confront new infections that are difficult to treat. In this article, we have reviewed the phenomenon of the emergence of resistance to antibacterials and we have tried to share some of the ideas, such as stewardship, sparing carbapenems, and organizational, microbiological, pharmacological, and knowledge tools, that we have considered most useful and effective for individualized decision making that takes into account the current context of multidrug resistance. The greatest challenge, therefore, of decision making in this context lies in determining an effective, optimal, and balanced empirical antibiotic treatment.
引用
收藏
页数:37
相关论文
共 167 条
  • [1] Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
    Abdul-Aziz, Mohd H.
    Alffenaar, Jan-Willem C.
    Bassetti, Matteo
    Bracht, Hendrik
    Dimopoulos, George
    Marriott, Deborah
    Neely, Michael N.
    Paiva, Jose-Artur
    Pea, Federico
    Sjovall, Fredrik
    Timsit, Jean F.
    Udy, Andrew A.
    Wicha, Sebastian G.
    Zeitlinger, Markus
    De Waele, Jan J.
    Roberts, Jason A.
    [J]. INTENSIVE CARE MEDICINE, 2020, 46 (06) : 1127 - 1153
  • [2] Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)
    Ahmed, Mohamed Abd El-Gawad El-Sayed
    Zhong, Lan-Lan
    Shen, Cong
    Yang, Yongqiang
    Doi, Yohei
    Tian, Guo-Bao
    [J]. EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 868 - 885
  • [3] Clinical review: Immunodepression in the surgical patient and increased susceptibility to infection
    Angele M.K.
    Faist E.
    [J]. Critical Care, 6 (4): : 298 - 305
  • [4] Antimicrobial-associated harm in critical care: a narrative review
    Arulkumaran, Nishkantha
    Routledge, Matthew
    Schlebusch, Sanmarie
    Lipman, Jeffrey
    Conway Morris, Andrew
    [J]. INTENSIVE CARE MEDICINE, 2020, 46 (02) : 225 - 235
  • [5] HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION
    ASSICOT, M
    GENDREL, D
    CARSIN, H
    RAYMOND, J
    GUILBAUD, J
    BOHUON, C
    [J]. LANCET, 1993, 341 (8844) : 515 - 518
  • [6] Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure
    Baggs, James
    Jernigan, John A.
    Halpin, Alison Laufer
    Epstein, Lauren
    Hatfield, Kelly M.
    McDonald, L. Clifford
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (07) : 1004 - 1012
  • [7] Tertiary peritonitis: considerations for complex team-based care
    Bass, Gary Alan
    Dzierba, Amy L.
    Taylor, Beth
    Lane-Fall, Meghan
    Kaplan, Lewis J.
    [J]. EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY, 2022, 48 (02) : 811 - 825
  • [8] Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections
    Bassetti, Matteo
    Garau, Javier
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 : IV23 - IV37
  • [9] Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
    Bassetti, Matteo
    Echols, Roger
    Matsunaga, Yuko
    Ariyasu, Mari
    Doi, Yohei
    Ferrer, Ricard
    Lodise, Thomas P.
    Naas, Thierry
    Niki, Yoshihito
    Paterson, David L.
    Portsmouth, Simon
    Torre-Cisneros, Julian
    Toyoizumi, Kiichiro
    Wunderink, Richard G.
    Nagata, Tsutae D.
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (02) : 226 - 240
  • [10] How to manage KPC infections
    Bassetti, Matteo
    Peghin, Maddalena
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2020, 7